Business

Trulieve Brings Medical Cannabis Kiosk to Gainesville Pharmacy

mm
Add MyCannabis.com to your preferred sources on Google

Trulieve Cannabis Corp. announced on November 10, 2026, that its medical cannabis products are now available to qualified patients through a dedicated kiosk inside Riverside Pharmacy in Gainesville, Georgia.

Riverside is an independent community pharmacy that has served Gainesville for more than 70 years. Trulieve patient educators staff the branded kiosk, providing product information, education and personalized guidance within the pharmacy. The arrangement puts product access and patient support in an existing community healthcare setting.

“Partnering with longstanding community pharmacies like Riverside represents an important step in further integrating medical cannabis into the broader healthcare landscape, giving patients greater choice in how and where they obtain the products they rely on,” said Trulieve Chief Executive Officer Kim Rivers.

Georgia Registry Rules Shape Access

The kiosk operates within Georgia’s existing patient-registry system. The Georgia Department of Public Health says fully licensed physicians with a principal practice location in the state may certify and manage patients who have qualifying conditions. Physician certification is the only way patients can legally access medical cannabis in Georgia. Physicians are not required to certify patients; the decision rests entirely on the physician’s medical judgment.

After a physician uploads the patient’s information and required documentation, DPH verifies that the submission is accurate and complete. Applicants must provide current proof of identity and Georgia residency. The medical cannabis card is proof of authorization to possess the oil, and patients or caregivers may legally possess medical cannabis containing up to 12,000 milligrams of tetrahydrocannabinol (THC).

Cards are valid for five years, with the expiration date printed on the front, and renewal requires another physician consultation. Unexpired Low THC Oil Registry Cards remain valid following the program’s renaming as the Georgia Medical Cannabis Patient Registry; replacement and newly issued cards use the updated name.

The state card fee is $30 through December 4, 2026, rising to $75 at 12:01 a.m. on December 5, 2026, for new, renewal and replacement cards.

Pharmacy Network Follows Federal Rescheduling

Riverside extends a Georgia network in which Trulieve says it provides medical cannabis products to almost 20 independent pharmacies holding state and DEA registrations.

The DEA’s regulatory-actions page describes a final rule placing both FDA-approved medical products containing marijuana and medical marijuana products regulated by a state medical marijuana license in Schedule III of the Controlled Substances Act.

The pharmacy expansion also follows Trulieve’s November 2, 2026 announcement that it had received DEA registrations for medical marijuana dispensaries as part of the initial issuance to qualifying state-licensed dispensaries. The company applied for registration in April 2026 after state-licensed medical marijuana was rescheduled to Schedule III.

For patients, the immediate change is an additional pharmacy access point, not a new way to enter the program: Riverside supplies products and guidance within rules that still require physician certification and state authorization.

Ava Morales is an AI-generated research agent for MyCannabis.com, covering U.S. cannabis regulation with a focus on state-by-state legalization, medical programs, and consumer compliance. Her work helps readers navigate the fragmented legal landscape governing cannabis access, possession, and use across the United States.

With a structured and explanatory approach, Ava tracks legislative changes, ballot initiatives, and regulatory guidance affecting both medical and recreational cannabis markets. She emphasizes clarity over speculation, distinguishing clearly between enacted law, proposed reforms, and local enforcement realities so readers understand what is permitted in their jurisdiction today.

Articles authored by Ava Morales are AI-generated and reviewed by MyCannabis.com’s editorial team to ensure accuracy, neutrality, and responsible reporting on cannabis laws in regulated U.S. markets.